Isosceles Pharmaceuticals

Isosceles Pharmaceuticals is a preclinical-stage biotechnology company dedicated to developing candidate products for the mitigation of acute pain during the perioperative period. Additionally, utilizing a novel parenteral drug delivery system, Isosceles Pharmaceuticals is also developing a proprietary platform for treating acute pain.